文献速递膀胱癌与上尿路尿路上皮癌

中国与美国上尿路尿路上皮癌临床病理特征及肿瘤学结局的多中心比较

A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States.
PubMed 文献 · J Urol · 2016-11-22

该研究回顾性汇总1998至2015年间在美国或中国三级医疗机构接受手术的上尿路尿路上皮癌患者资料,比较两国患者的临床病理特征与肿瘤学结局。共纳入775例患者,中国451例、美国324例,中位随访42个月。结果显示两国患者特征存在差异,但原产国并不预测局部复发或癌症特异性生存。

要点

  • 美国患者更多为男性(65% vs 44%)和吸烟者(79% vs 18%),平均ASA评分更差(2.7 vs 2.2),既往膀胱癌比例更高(41% vs 4%)。
  • 中国患者术前肾积水(56% vs 40%)、高级别病理(98% vs 77%)、肌层浸润(64% vs 38%)及淋巴结转移(26% vs 6%)比例更高。
  • 美国患者Kaplan-Meier分析总生存更差(p=0.049),但原产国未预测局部复发或癌症特异性生存。

核心结论

  • 中国与美国上尿路尿路上皮癌队列的患者及疾病特征存在差异。
  • 中国患者就诊时相对更健康,但更常表现出不良病理特征。
  • 评估和管理模式可能解释这些差异,病理发现可能反映疾病潜在发病机制的不同。
  • 需要额外研究来进一步刻画这些差异。

研究设计与样本

  • 回顾性汇总1998年至2015年间在美国或中国三级医疗机构接受手术治疗的上尿路尿路上皮癌患者的临床病理和肿瘤学结局数据。
  • 共纳入775例患者,其中中国451例,美国324例,中位随访42个月。
  • 在排除接受全身化疗的患者后获取肿瘤学终点,包括膀胱内复发和癌症特异性生存。
  • 采用多变量Cox回归确定各国不良肿瘤学结局的预测因素。

主要发现

  • 美国患者更常见为男性(65% vs 44%)和吸烟者(79% vs 18%),平均ASA评分更差(2.7 vs 2.2),既往膀胱癌比例更高(41% vs 4%),所有p<0.001。
  • 中国患者更常有术前肾积水(56% vs 40%)、高级别病理(98% vs 77%)、肌层浸润(64% vs 38%)和淋巴结转移(26% vs 6%),所有p<0.001。
  • Kaplan-Meier分析显示美国患者总生存更差(p=0.049)。
  • 原产国未预测局部复发或癌症特异性生存。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We evaluated differences in clinicopathological characteristics and oncologic outcomes between patients with upper tract urothelial carcinoma in mainland China and the United States. MATERIALS AND METHODS: We retrospectively compiled clinicopathological and oncologic outcomes data on patients with upper tract urothelial carcinoma treated surgically at tertiary care medical facilities in the United States or China from 1998 to 2015. Baseline demographics, comorbidities and pathological features were evaluated. Oncologic end points, including intravesical recurrence and cancer specific survival, were obtained after excluding patients who received systemic chemotherapy. Multivariable Cox regression was performed to determine predictors of adverse oncologic outcomes for each country. RESULTS: A total of 775 patients with upper tract urothelial carcinoma were identified, including 451 in China and 324 in the United States. Median followup was 42 months. American patients were more frequently male (65% vs 44%) and smokers (79% vs 18%), and had a worse mean ASA® (American Society of Anesthesiologists®) score (2.7 vs 2.2) and prior bladder cancer (41% vs 4%, all p <0.001). Chinese patients more often had preoperative hydronephrosis (56% vs 40%), high grade pathology (98% vs 77%), muscle invasion (64% vs 38%) and nodal metastases (26% vs 6%, all p <0.001). American patients had worse overall survival on Kaplan-Meier analysis (p = 0.049). However, country of origin did not predict local relapse or cancer specific survival. CONCLUSIONS: Patient and disease characteristics of upper tract urothelial carcinoma differed between the Chinese and American cohorts. Chinese patients appeared relatively healthier at presentation but more often exhibited adverse pathological features. While evaluation and management patterns may account for these variations, the pathological findings may reflect a differential underlying pathogenesis of disease. Additional study is warranted to further characterize these differences.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Singla N, Fang D, Su X, et al. A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States. J Urol. 2016. PMID: 27887951. doi:10.1016/j.juro.2016.11.094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。